Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Chunshu Jia"'
Publikováno v:
Cellular Physiology and Biochemistry, Vol 48, Iss 2, Pp 815-826 (2018)
Background/Aims: microRNA (miR)-374a plays a crucial role in cancer progression by promoting the metastasis and proliferation of various types of malignant tumors. Because its role in bladder cancer is unknown, we investigated whether miR-374a affect
Externí odkaz:
https://doaj.org/article/1fd3b8f7ac284d4ca6aaaebe51d664ed
Autor:
Xiaoliang Chen, Fuquan Jiang, Chunshu Jia, Ming Liu, Yonghao Nan, Licheng Qu, Qingkuo Kong, Fangfang Hou, Wenshan Luo, Wanli Na, Xuefei Jin, Jiufeng Tan
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Non-muscle invasive bladder cancer (NMIBC) patients often have fewer treatment options, and suffer the progression of disease due to mechanisms that are not clear, as well as due to its diversity. This study was designed to explore the molecular mech
Externí odkaz:
https://doaj.org/article/efb3a9cf85b8474491defc9b89862dbb
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0225463 (2019)
ObjectiveThe antiphospholipid syndrome (APS) is an important cause of acquired thromboembolic complications and pregnancy morbidity. The pathogenic mechanisms that damage the fetal-maternal unit and cause abnormal placental development are incomplete
Externí odkaz:
https://doaj.org/article/89ee4e6cc7cc4e55bdff6c1ee2d989a9
Autor:
Fengyan Jin, Huifan Ji, Chunshu Jia, Ulf Brockmeier, Dirk M Hermann, Eric Metzen, Yingqiao Zhu, Baorong Chi
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47161 (2012)
Combination treatment with endostar, a novel modified endostatin, and cytotoxic chemotherapies showed a survival benefit in Chinese clinical trials. However, the exact mechanism for this synergism remains unclear. In this study, we report for the fir
Externí odkaz:
https://doaj.org/article/ac815a1fea9e4b59921ca38c3da93286
Publikováno v:
Molecular Reproduction and Development. 86:1561-1568
Dysregulation of the cell cycle is common in human tumorigenesis. Therefore, CDK4/6 inhibitors targeting the cell cycle have been developed, and their antiapoptotic effects have been highly correlated with potential clinical therapies. The aim of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::048f61253a05ce1895520af52cc86ca7
https://doi.org/10.1002/mrd.23241
https://doi.org/10.1002/mrd.23241
Publikováno v:
Molecular Reproduction and Development. 86:292-297
Polycystic ovary syndrome (PCOS) is a set of symptoms caused by elevated androgens (male hormones) in females. PCOS is the most common endocrine disorder among women between 18 and 44 years. Currently, the pathogenesis of PCOS remains unclear. Liquid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e9b8ac3eb7554df8b2f64225e071519
https://doi.org/10.1002/mrd.23104
https://doi.org/10.1002/mrd.23104
PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis
Publikováno v:
International Journal of Biological Sciences
Cisplatin-based chemotherapy often results in the development of chemo-resistance when used to treat bladder cancer (BC), which is difficult to overcome. Recent data indicate that pyruvate kinase M2 (PKM2), a glycolytic enzyme for Warburg effect, is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5874abd7483fc87a7344f3132417400
https://doi.org/10.7150/ijbs.27854
https://doi.org/10.7150/ijbs.27854
Publikováno v:
Cellular Physiology and Biochemistry, Vol 48, Iss 2, Pp 815-826 (2018)
Background/Aims: microRNA (miR)-374a plays a crucial role in cancer progression by promoting the metastasis and proliferation of various types of malignant tumors. Because its role in bladder cancer is unknown, we investigated whether miR-374a affect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d40c737cba5562552233cf040a7e7e8
https://doi.org/10.1159/000491911
https://doi.org/10.1159/000491911
Autor:
Licheng Qu, Fuquan Jiang, Wanli Na, Ming Liu, Fangfang Hou, Chunshu Jia, Jiufeng Tan, Wenshan Luo, Yonghao Nan, Xiaoliang Chen, Xuefei Jin, Qingkuo Kong
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology, Vol 9 (2019)
Non-muscle invasive bladder cancer (NMIBC) patients often have fewer treatment options, and suffer the progression of disease due to mechanisms that are not clear, as well as due to its diversity. This study was designed to explore the molecular mech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aec2f1d92b3de63190d884407f140d0
http://europepmc.org/articles/PMC6604748
http://europepmc.org/articles/PMC6604748
Publikováno v:
Molecular reproduction and development. 86(11)
Dysregulation of the cell cycle is common in human tumorigenesis. Therefore, CDK4/6 inhibitors targeting the cell cycle have been developed, and their antiapoptotic effects have been highly correlated with potential clinical therapies. The aim of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4aa8d9d27a18474ef5e8f72e9b1b6228
https://pubmed.ncbi.nlm.nih.gov/31339188
https://pubmed.ncbi.nlm.nih.gov/31339188